Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men

NCT02097680 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Letrozole
DRUG: Placebo

Sponsor

University Hospital, Ghent